¼¼°èÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À¹Ì¸Þƽ½º ½ÃÀå º¸°í¼­(2025³â)
Medical Biomimetics Global Market Report 2025
»óǰÄÚµå : 1693247
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,319,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,134,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,949,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀÇ·á¿ë ¹ÙÀÌ¿À¹Ì¸Þƽ½º ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 6.4%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î 506¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº Àå±â ÀÌ½Ä ¼ö¿ä Áõ°¡, »ýü ¸ð¹æ ÀÀ¿ë ÇÁ·Î±×·¥ÀÇ ÀÎÁöµµ Çâ»ó, ÀÇ·á ÁöÃâ Áõ°¡, »ý¸í°øÇÐ ºÎ¹®ÀÇ È®´ë, Á¶Á÷ °øÇÐÀÇ ¹ßÀü µî¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â »ýü¿¡¼­ ¿µ°¨À» ¹ÞÀº Àΰø º¸Á¶±â, »ýü ¸ð¹æ ¼¾¼­, ÇÕ¼º»ý¹°ÇÐ ¾ÖÇø®ÄÉÀ̼Ç, ½º¸¶Æ® ¾à¹°Àü´Þ ½Ã½ºÅÛ, »ýü¿¡¼­ ¿µ°¨À» ¹ÞÀº ·Îº¿, ¸ÂÃãÇü ÀÇ·á, 3D ÇÁ¸°ÆÃ ±â¼ú, Áø´Ü¿¡¼­ÀÇ ÀΰøÁö´É, ³ª³ë±â¼ú ¾ÖÇø®ÄÉÀ̼Ç, Àç»ýÀÇ·á, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¾ÖÇø®ÄÉÀ̼Ç, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¾ÖÇø®ÄÉÀ̼Ç, ³ª³ëÅ×Å©³î·¯Áö ¾ÖÇø®ÄÉÀ̼Ç, Àç»ýÀÇ·á ¾ÖÇø®ÄÉÀÌ¼Ç µîÀÌ ÀÖ½À´Ï´Ù. ³ª³ë±â¼ú ÀÀ¿ë, Àç»ýÀÇ·á µîÀÌ ÀÖ½À´Ï´Ù.

ºñ¸¸°ú ½ÉÀ庴 À¯º´·üÀÇ Áõ°¡´Â ÀÇ·á¿ë ¹ÙÀÌ¿À¹Ì¸Þƽ½º ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñ¸¸Àº °úµµÇÑ Ã¼Áö¹æÀÌ °Ç°­¿¡ ÇØ·Î¿î ¼öÁØÀ¸·Î ÃàÀûµÈ »óÅÂÀ̸ç, ½ÉÀ庴Àº ½ÉÀå°ú Ç÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ÁúȯÀ» Æ÷ÇÔÇÕ´Ï´Ù. ¹ÙÀÌ¿À¹Ì¸Þƽ½ºÀº ´ç´¢, ºñ¸¸ µîÀÇ Áõ»óÀ» °¡Áø »ç¶÷µéÀÇ °Ç°­°ü¸®¸¦ µ½´Â º¸Á¶±â±¸³ª ÀÇÁ· µî º¸Á¶±â±¸ °³¹ß¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 8¿ù ¹Ì±¹ ºñ¿µ¸® ÀÇ·á´ÜüÀÎ ¹Ì±¹½ÉÀåÇÐȸ(American College of Cardiology)ÀÇ º¸°í¼­´Â 2025³âºÎÅÍ 2060³â±îÁö ¹Ì±¹ ³» 4´ë ½ÉÇ÷°ü°è À§Çè¿äÀÎÀÌ ¸ðµÎ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. °¡Àå ¸¹ÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÈ °ÍÀº ´ç´¢º´À¸·Î 39.3% Áõ°¡ÇÑ 5,500¸¸ ¸í, ´ÙÀ½À¸·Î ÀÌ»óÁöÁúÇ÷Áõ(27.6% Áõ°¡ÇÑ 1¾ï 2,600¸¸ ¸í), °íÇ÷¾Ð(25.1% Áõ°¡ÇÑ 1¾ï 6,200¸¸ ¸í), ºñ¸¸(18.3% Áõ°¡ÇÑ 1¾ï 2,600¸¸ ¸í)ÀÌ µÚ¸¦ À̾ú½À´Ï´Ù. ¶ÇÇÑ ½ÉÇ÷°üÁúȯ, ƯÈ÷ ³úÁ¹Áß(33.8%¡æ1,500¸¸ ¸í), ½ÉºÎÀü(33.4%¡æ1,300¸¸ ¸í), ÇãÇ÷¼º ½ÉÀåÁúȯ(30.7%¡æ2,900¸¸ ¸í), ½ÉÀ帶ºñ(16.9%¡æ1,600¸¸ ¸í)ÀÇ ºñÀ²µµ Å©°Ô Áõ°¡ÇÏ¿´½À´Ï´Ù. °á°úÀûÀ¸·Î ºñ¸¸°ú ½ÉÀåÁúȯÀÇ Áõ°¡À²ÀÌ ÀÇ·á¿ë ¹ÙÀÌ¿À¹Ì¸Þƽ½º ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¹ÙÀÌ¿À¹Ì¸Þƽ½º ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀº ½ÃÀå ¼öÀͼºÀ» ³ôÀ̱â À§ÇØ ºÀÇÕ»ç ¾ÞÄ¿ ½Ã½ºÅÛ°ú °°Àº ÷´Ü ±â¼úÀ» žÀçÇÑ Çõ½ÅÀûÀÎ Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ºÀÇÕ»ç ¾ÞÄ¿ ½Ã½ºÅÛÀº Á¤Çü¿Ü°ú ¹× ½ºÆ÷Ã÷ ÀÇÇÐ ¼ö¼ú¿¡¼­ ÈûÁÙ, ÀÎ´ë µî ¿¬ºÎÁ¶Á÷À» »À¿¡ °íÁ¤ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ºÀÇÕ»ç ¾ÞÄ¿ ½Ã½ºÅÛÀº ¿¬ºÎÁ¶Á÷°ú »ÀÀÇ ÀÚ¿¬½º·¯¿î °áÇÕÀ» ÀçÇöÇÏ°í °³¼±Çϱâ À§ÇØ ³ë·ÂÇϸç, ÀÎüÀÇ »ý¸®Àû Á¶Á÷ °áÇÕÀ» ¹Ý¿µÇÏ¿© ±â´ÉÀû, »ý¿ªÇÐÀûÀ¸·Î ÃÖÀûÈ­µÈ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¿¡ º»»ç¸¦ µÐ ´Ù±¹Àû ÀÇ·á ±â¼ú ±â¾÷ÀÎ ½ºÆ®¶óÀÌÄ¿ ÄÚÆÛ·¹À̼Ç(Striker Corporation)Àº 2022³â 12¿ù ÀÏȸ¿ë ºÀÇÕ»ç ¾ÞÄ¿ ½Ã½ºÅÛÀÎ ½ÃÆ®·¹ÇȽº(Citrefix)¸¦ Ãâ½ÃÇÏ¿´½À´Ï´Ù. Citrefix´Â »À È­ÇÐÀ» ¸ð¹æÇϵµ·Ï Ưº°È÷ ¼³°èµÈ ±¸¿¬»ê Æú¸®¸Ó·Î ¸¸µç ¿¤¶ó½ºÅä¸Ó ¼ÒÀçÀÎ CitregenÀ» »ç¿ëÇÏ¿© ÀçÈí¼ö °¡´ÉÇÑ »ýü ¸ð¹æÇü ¾ÞÄ¿ º»Ã¼¸¦ ÅëÇÕÇÑ Á¦Ç°ÀÔ´Ï´Ù. ÀÌ µðÀÚÀÎÀº ¸¸¼º ¿°ÁõÀ» À¯¹ßÇÏÁö ¾Ê°í Èí¼ö¸¦ Á¦¾îÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¦Ç°Àº ÀÏȸ¿ë ºÀÇÕ»ç ¾ÞÄ¿ ½Ã½ºÅÛÀ¸·Î, Á¤Çü¿Ü°ú ¼ö¼ú¿¡ »ç¿ëµÉ ¶§ ÀÌ½ÄµÈ Á¶Á÷ÀÇ Ä¡À¯¿Í °Ç°­ÇÑ »ÀÀÇ ¼ºÀåÀ» µ½µµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Medical biomimetics refers to the development and application of innovative technologies that replicate and enhance natural physiological processes, aiming to create functional and biomechanically optimized solutions in the field of healthcare. Medical biomimetics plays a crucial role in advancing the field of artificial organs and tissues. It is extensively employed in the design of drug delivery systems that emulate biological processes, improving the precision and efficiency of targeted medication delivery.

The main types of medical biomimetics are cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the study and application of principles inspired by nature to develop innovative solutions for heart and vascular-related medical challenges. These are used in various applications such as wound healing, tissue engineering, drug delivery, and others and are used by various end-users such as hospitals, specialty clinics, and others.

The main types of medical biomimetics are cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the study and application of principles inspired by nature to develop innovative solutions for heart and vascular-related medical challenges. These are used in various applications such as wound healing, tissue engineering, drug delivery, and others and are used by various end-users such as hospitals, specialty clinics, and others.

The medical biomimetics market size has grown strongly in recent years. It will grow from $36.6 billion in 2024 to $39.56 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increased biomimetic materials, increased research funding, aging population, rising chronic diseases.

The medical biomimetics market size is expected to see strong growth in the next few years. It will grow to $50.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing demand for organ transplants, growing awareness of biomimetics applications, rising healthcare expenditure, expanding biotechnology sector, advancements in tissue engineering. Major trends in the forecast period include Bio-inspired prosthetics, biomimetic sensors, synthetic biology applications, smart drug delivery systems, biologically inspired robotics, Personalized medicine, 3D printing technologies, artificial intelligence in diagnostics, nanotechnology applications, regenerative medicine.

The rising prevalence of obesity and heart disease is expected to drive the growth of the medical biomimetics market. Obesity is a condition in which excess body fat accumulates to unhealthy levels, while heart disease encompasses a variety of conditions that affect the heart and blood vessels. Biomimetics plays a crucial role in developing assistive devices, such as orthotics and prosthetics, that can help individuals with conditions like diabetes or obesity manage their health. For example, in August 2022, a report by the American College of Cardiology, a US-based non-profit medical association, projected an increase in all four major cardiovascular risk factors in the United States from 2025 to 2060. The largest rise was anticipated in diabetes, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The study also indicated significant increases in cardiovascular disease rates, particularly for stroke (33.8% to 15 million), heart failure (33.4% to 13 million), ischemic heart disease (30.7% to 29 million), and heart attack (16.9% to 16 million). As a result, the growing rates of obesity and heart disease are contributing to the expansion of the medical biomimetics market.

Major companies operating in the medical biomimetics market are focused on developing innovative products with advanced technologies, such as suture anchor system to increase their profitability in market. A suture anchor system is a medical device used in orthopedic and sports medicine procedures for securing soft tissues, such as tendons or ligaments, to bone. Suture anchor systems strive to replicate and improve upon the natural attachment of soft tissues to bone, offering a functional and biomechanically optimized solution mirroring physiological tissue connections in the human body. For instance, in December 2022, Stryker Corporation, a US-based multinational medical technologies company, launches Citrefix, a disposable suture anchor system, incorporates a resorbable biomimetic anchor body using Citregen, an elastomeric material crafted from a citrate polymer, specifically engineered to emulate bone chemistry. This design allows for controlled resorption without inducing chronic inflammation. It is a disposable suture anchor system that is designed to help grafted tissue heal and healthy bone grow when used in orthopedic surgical applications.

In July 2024, Edwards Lifesciences, a US-based medical technology company, acquired Innovalve Bio Medical for $300 million. This acquisition allows Edwards to reinforce its position in the expanding market for TMVR devices, which is expected to experience significant growth in the coming years. Innovalve Bio Medical is an Israel-based provider of medical biomimetics.

Major companies operating in the medical biomimetics market are BASF SE, Bayer Aktiengesellschaft, Abbott Laboratories, Stryker Corporation, Zimmer Biomet Holdings Inc., Otsuka Medical Device Company Ltd., LivaNova PLC, Ossur hf., Forschungszentrum Julich GmbH, Biohorizons Implant Systems Inc., Inventia Plc, Blatchford Limited, Keystone Dental Corporation, Xtant Medical Holdings Inc., AVINENT Science and Technology, SynTouch Inc., Curasan Inc., CorNeat Vision Inc., Hstar Technologies Co. Ltd., Veryan Medical Ltd., Swedish Biomimetics 3000 ApS, Osteopore International Pte Ltd., KitoTech Medical Ltd., Vandstrom Inc.

North America was the largest region in the medical biomimetics market in 2024. The regions covered in the medical biomimetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical biomimetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical biomimetics market consists of sales of diagnostic tools, wound healing products, bio-inspired robotics, bioelectronic devices and regenerative medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Biomimetics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical biomimetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical biomimetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical biomimetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Medical Biomimetics Market Characteristics

3. Medical Biomimetics Market Trends And Strategies

4. Medical Biomimetics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Medical Biomimetics Growth Analysis And Strategic Analysis Framework

6. Medical Biomimetics Market Segmentation

7. Medical Biomimetics Market Regional And Country Analysis

8. Asia-Pacific Medical Biomimetics Market

9. China Medical Biomimetics Market

10. India Medical Biomimetics Market

11. Japan Medical Biomimetics Market

12. Australia Medical Biomimetics Market

13. Indonesia Medical Biomimetics Market

14. South Korea Medical Biomimetics Market

15. Western Europe Medical Biomimetics Market

16. UK Medical Biomimetics Market

17. Germany Medical Biomimetics Market

18. France Medical Biomimetics Market

19. Italy Medical Biomimetics Market

20. Spain Medical Biomimetics Market

21. Eastern Europe Medical Biomimetics Market

22. Russia Medical Biomimetics Market

23. North America Medical Biomimetics Market

24. USA Medical Biomimetics Market

25. Canada Medical Biomimetics Market

26. South America Medical Biomimetics Market

27. Brazil Medical Biomimetics Market

28. Middle East Medical Biomimetics Market

29. Africa Medical Biomimetics Market

30. Medical Biomimetics Market Competitive Landscape And Company Profiles

31. Medical Biomimetics Market Other Major And Innovative Companies

32. Global Medical Biomimetics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Biomimetics Market

34. Recent Developments In The Medical Biomimetics Market

35. Medical Biomimetics Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â